Financials • Specialty Insurers
$31.83 ▼ -0.12
(-0.38%)
MKT CAP: $4.44B • VOL: 1.67M
52W L $16 52W H $33
BWIN // SEC EDGAR XBRL STANDARDIZED FINANCIAL STATEMENTS (FA <GO>)
| LINE ITEM (USD / %) | FY 2025
FILED 2025-12-31 | FY 2024
FILED 2024-12-31 | FY 2023
FILED 2023-12-31 |
|---|---|---|---|
| Revenue (Total Sales) | $1.49B | $1.38B | $1.21B |
| YoY Revenue Growth % | +8.5% | +13.6% | — |
| Gross Profit | $657.2M | $605.9M | $533.2M |
| Gross Margin % | 44.0% | 44.0% | 44.0% |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | $73.9M | $60.6M | -$42.6M |
| Operating Margin % | 4.9% | 4.4% | -3.5% |
| Net Income (GAAP) | -$54.2M | -$41.1M | -$164.0M |
| EBITDA (Normalized) | $127.7M | $110.2M | $1.1M |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | -$29.4M | $51.5M | $46.0K |
| Capital Expenditures (CapEx) | $67.2M | $62.0M | $54.5M |
| Free Cash Flow (FCF) | -$96.6M | -$10.5M | -$54.5M |
| FCF Margin % | -6.5% | -0.8% | -4.5% |
| Return on Invested Capital (ROIC %) | 3.4% | 2.9% | -2.3% |
| Cash & Short-Term Equivalents | $123.7M | $90.0M | $268.6M |
| Total Debt (Short + Long Term) | $1.25B | $1.14B | $571.5M |
| Total Stockholders' Equity | $600.2M | $583.2M | $1.17B |
NO QUARTERLY 10-Q XBRL STATEMENTS AVAILABLE IN CURRENT CACHE FOR BWIN.